Xing Chang

925 total citations · 3 hit papers
20 papers, 412 citations indexed

About

Xing Chang is a scholar working on Molecular Biology, Epidemiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Xing Chang has authored 20 papers receiving a total of 412 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 6 papers in Epidemiology and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Xing Chang's work include Mitochondrial Function and Pathology (11 papers), Autophagy in Disease and Therapy (4 papers) and ATP Synthase and ATPases Research (3 papers). Xing Chang is often cited by papers focused on Mitochondrial Function and Pathology (11 papers), Autophagy in Disease and Therapy (4 papers) and ATP Synthase and ATPases Research (3 papers). Xing Chang collaborates with scholars based in China, Australia and United Kingdom. Xing Chang's co-authors include Hao Zhou, Xiao Zhang, Ruibin Li, Xin Liu, Guangtong Dong, Xinyao Sun, Haowen Zhuang, Chun Li, Junyan Wang and Ying Tong and has published in prestigious journals such as Frontiers in Pharmacology, Frontiers in Physiology and Phytotherapy Research.

In The Last Decade

Xing Chang

19 papers receiving 404 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation

2024 83 citations Ruibin Li, Hao Zhou et al. Cellular & Molecular Biology Letters profile →
Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction

2024 70 citations Guangtong Dong, Xinyao Sun et al. Angiogenesis profile →
Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy

2024 50 citations Junyan Wang, Haowen Zhuang et al. International Journal of Biological Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xing Chang China	10	254	88	73	55	45	20	412
Qiaomin Wu China	8	239 0.9×	66 0.8×	78 1.1×	70 1.3×	38 0.8×	18	404
Xuanke Guan China	8	255 1.0×	69 0.8×	83 1.1×	75 1.4×	39 0.9×	16	413
Jiayu Jin China	8	321 1.3×	60 0.7×	72 1.0×	52 0.9×	71 1.6×	12	463
Ke‐Xue Li China	12	207 0.8×	63 0.7×	83 1.1×	95 1.7×	73 1.6×	17	465
Haixu Song China	11	238 0.9×	57 0.6×	122 1.7×	86 1.6×	66 1.5×	29	450
Bipradas Roy United States	10	187 0.7×	97 1.1×	83 1.1×	46 0.8×	48 1.1×	19	438
Yanqing Chi China	13	259 1.0×	79 0.9×	109 1.5×	26 0.5×	29 0.6×	23	577
Songping Yu China	12	182 0.7×	55 0.6×	57 0.8×	27 0.5×	65 1.4×	25	398
Xiyun Bian China	13	280 1.1×	41 0.5×	82 1.1×	73 1.3×	54 1.2×	29	472
Saizhu Wu China	13	168 0.7×	75 0.9×	85 1.2×	48 0.9×	67 1.5×	20	429

Countries citing papers authored by Xing Chang

Since Specialization

Citations

This map shows the geographic impact of Xing Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Chang more than expected).

Fields of papers citing papers by Xing Chang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xing Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Chang. The network helps show where Xing Chang may publish in the future.

Co-authorship network of co-authors of Xing Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Xing Chang. A scholar is included among the top collaborators of Xing Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Chang. Xing Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chang, Xing, Siyuan Zhou, Qin Zhang, et al.. (2025). Potential Candidates of Natural Antioxidants From Herbs for Treating Lung Disorders: Focus on Redox Balance and Natural Products. Phytotherapy Research. 39(8). 3353–3385. 9 indexed citations

Liu, Xinxin, Yuan Ma, Xiao Wen Zhang, et al.. (2025). Cross-regulatory mechanisms linking ferroptosis, epigenetics, and circadian rhythm to mitochondrial quality control in diabetic cardiomyopathy. Journal of Advanced Research.

Wang, Junqi, Nan Lü, Zhijiang Guo, et al.. (2025). Hepatic ischemia-reperfusion and mitochondrial quality control: potential therapeutic targets. International Immunopharmacology. 163. 115267–115267. 1 indexed citations

Wu, Qiaomin, Zhaoqi Yan, Siyuan Zhou, et al.. (2025). Tanshinone IIA modulates Sirt5 and Metll3 interaction to govern mitochondria-endoplasmic reticulum unfolded protein response in coronary microvascular injury. Phytomedicine. 145. 156982–156982. 10 indexed citations

Zhang, Xiaohan, et al.. (2025). Xin-Fu-Kang oral liquid mitigates chronic heart failure through NR4A1-Dependent regulation of endoplasmic reticulum-mitochondrial crosstalk in Cardiomyocytes. Phytomedicine. 140. 156467–156467. 1 indexed citations

Dong, Guangtong, et al.. (2024). Emerging insights into the pathogenesis and therapeutic strategies for vascular endothelial injury-associated diseases: focus on mitochondrial dysfunction. Angiogenesis. 27(4). 623–639. 70 indexed citations breakdown →

Dong, Guangtong, et al.. (2024). Advances in pathogenesis and treatment of vascular endothelial injury-related diseases mediated by mitochondrial abnormality. Frontiers in Pharmacology. 15. 1422686–1422686. 14 indexed citations

Li, Ruibin, et al.. (2024). New insights into the role of mitochondrial metabolic dysregulation and immune infiltration in septic cardiomyopathy by integrated bioinformatics analysis and experimental validation. Cellular & Molecular Biology Letters. 29(1). 21–21. 83 indexed citations breakdown →

Guo, Zhijiang, Jing Gao, Bei Zhou, et al.. (2024). Enhancement of Mitochondrial Homeostasis: A Novel Approach to Attenuate Hypoxic Myocardial Injury. International Journal of Medical Sciences. 21(15). 2897–2911. 9 indexed citations

10.

Wang, Yanli, Qiaomin Wu, Jinfeng Liu, et al.. (2024). Mechanisms involved in the regulation of mitochondrial quality control by PGAM5 in heart failure. Cell Stress and Chaperones. 29(3). 510–518. 7 indexed citations

11.

Zhuang, Haowen, Xiaocui Yang, Zhijiang Guo, et al.. (2024). Exploring the Mechanism of Ferroptosis Induction by Sappanone A in Cancer: Insights into the Mitochondrial Dysfunction Mediated by NRF2/xCT/GPX4 Axis. International Journal of Biological Sciences. 20(13). 5145–5161. 44 indexed citations

12.

Chang, Xing, et al.. (2024). Genetic basis and causal relationship between atrial fibrillation and sinus node dysfunction: Evidence from comprehensive genetic analysis. International Journal of Cardiology. 418. 132609–132609. 2 indexed citations

13.

Wu, Qiaomin, Xing Chang, Yanli Wang, et al.. (2024). The electrophysiological effects of Tongyang Huoxue granules on the ignition phase during hypoxia/reoxygenation injury in sinoatrial node cells. Frontiers in Physiology. 15. 1402478–1402478. 1 indexed citations

14.

Zhang, Xiaohan, et al.. (2024). Shaping cardiac destiny: the role of post-translational modifications on endoplasmic reticulum – mitochondria crosstalk in cardiac remodeling. Frontiers in Pharmacology. 15. 1423356–1423356. 4 indexed citations

15.

Chang, Xing, Jianguo Lin, Ying Tan, et al.. (2024). BuyangHuanwu Decoction alleviates Endothelial Cell Apoptosis and Coronary Microvascular Dysfunction via Regulation of the MAPKK4/p38 Signaling Axis. International Journal of Medical Sciences. 21(13). 2464–2479. 5 indexed citations

16.

Wang, Junyan, Haowen Zhuang, Lianqun Jia, et al.. (2024). Nuclear receptor subfamily 4 group A member 1 promotes myocardial ischemia/reperfusion injury through inducing mitochondrial fission factor-mediated mitochondrial fragmentation and inhibiting FUN14 domain containing 1-depedent mitophagy. International Journal of Biological Sciences. 20(11). 4458–4475. 50 indexed citations breakdown →

17.

Chang, Xing, Hao Zhou, Jinlin Hu, et al.. (2024). Targeting mitochondria by lipid-selenium conjugate drug results in malate/fumarate exhaustion and induces mitophagy-mediated necroptosis suppression. International Journal of Biological Sciences. 20(14). 5793–5811. 12 indexed citations

18.

Du, Yingzhen, Pingjun Zhu, Tian Xia, et al.. (2024). DNA-PKcs Phosphorylates Cofilin2 to Induce Endothelial Dysfunction and Microcirculatory Disorder in Endotoxemic Cardiomyopathy. Research. 7. 331–331. 9 indexed citations

19.

Li, Haixia, Dong Chen, Xiaoqin Zhang, et al.. (2023). Screening of an FDA-approved compound library identifies apigenin for the treatment of myocardial injury. International Journal of Biological Sciences. 19(16). 5233–5244. 10 indexed citations

20.

Zhang, Xiao, Hao Zhou, & Xing Chang. (2023). Involvement of mitochondrial dynamics and mitophagy in diabetic endothelial dysfunction and cardiac microvascular injury. Archives of Toxicology. 97(12). 3023–3035. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact